GLP-1 Drugs and Tuberculosis Risk in People With Type 2 Diabetes
A new study published in Nature Communications is putting a widely used class of diabetes medicines under the microscope, asking ...
A new study published in Nature Communications is putting a widely used class of diabetes medicines under the microscope, asking ...
The escalating prescription of GLP-1 receptor agonists, medicines primarily targeting type 2 diabetes and weight management, is presenting an emerging ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine